Compare LEGN & MC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LEGN | MC |
|---|---|---|
| Founded | 2014 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 5.3B |
| IPO Year | 2020 | 2014 |
| Metric | LEGN | MC |
|---|---|---|
| Price | $22.14 | $77.16 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 9 |
| Target Price | $69.33 | ★ $74.13 |
| AVG Volume (30 Days) | ★ 2.1M | 723.6K |
| Earning Date | 11-12-2025 | 02-04-2026 |
| Dividend Yield | N/A | ★ 3.35% |
| EPS Growth | N/A | ★ 446.16 |
| EPS | N/A | ★ 3.17 |
| Revenue | $909,045,000.00 | ★ $1,467,580,000.00 |
| Revenue This Year | $68.20 | $27.41 |
| Revenue Next Year | $47.77 | $18.00 |
| P/E Ratio | ★ N/A | $24.45 |
| Revenue Growth | ★ 74.75 | 51.19 |
| 52 Week Low | $20.21 | $47.00 |
| 52 Week High | $45.30 | $82.89 |
| Indicator | LEGN | MC |
|---|---|---|
| Relative Strength Index (RSI) | 42.47 | 66.67 |
| Support Level | $20.21 | $71.53 |
| Resistance Level | $24.12 | $75.35 |
| Average True Range (ATR) | 1.05 | 2.34 |
| MACD | 0.30 | 0.23 |
| Stochastic Oscillator | 47.57 | 90.81 |
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
Moelis & Co is an independent investment bank that provides strategic and financial advice to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. The company assists its clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all industry sectors. It also advises clients on their critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. it generates revenue from advisory transactions. The firm derives a majority of its revenue from the United States followed by Europe and the rest of the World.